Home LiteratureArticle Details
PMID: 65626 Published · ppublish English Case Reports Comparative Study Editorial

Amikacin resistance developing in patients with Pseudomonas aeruginosa bronchopneumonia.

Lancet (London, England) ·Vol. 1 ·No. 8010 ·1977-03-05 ·Pages 537-8

Amirak ID, Williams RJ, Noone P, Wills MR

Abstract

暂无摘要

MeSH Terms
Amikacin/therapeutic use Bronchopneumonia/drug therapy Drug Resistance, Microbial Female Humans Kanamycin/analogs & derivatives Middle Aged Pseudomonas Infections/drug therapy Pseudomonas aeruginosa/drug effects
Chemicals
Kanamycin Amikacin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Amirak I D
Williams R J
Noone P
Wills M R
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(77)91391-5
Published
1977-03-05
Pages
537-8
Language
English
Region
England
NLM ID
2985213R
Subset
IM
External Links
PubMed source DOI: 10.1016/s0140-6736(77)91391-5 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2